Genomic predictors of outcome and treatment response in breast cancer, Mol Diagn Ther, vol.13, pp.73-90, 2009. ,
Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000. ,
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, vol.98, pp.10869-10874, 2001. ,
The molecular portraits of breast tumors are conserved across microarray platforms, BMC Genomics, vol.7, p.96, 2006. ,
Gene-expression signatures in breast cancer, N Engl J Med, vol.360, pp.790-800, 2009. ,
Comprehensive profiling of 8p11-12 amplification in breast cancer, Molecular Cancer Research, vol.3, pp.655-667, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-00158812
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer, Genes Chromosomes Cancer, vol.45, pp.1033-1040, 2006. ,
Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array, Clin Cancer Res, vol.15, pp.441-451, 2009. ,
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies, Cancer Cell, vol.10, pp.529-541, 2006. ,
Regional copy number-independent deregulation of transcription in cancer, Nat Genet, vol.38, pp.1386-1396, 2006. ,
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer Cell, vol.10, pp.515-527, 2006. ,
Integrated profiling of basal and luminal breast cancers, Cancer Res, vol.67, pp.11565-11575, 2007. ,
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer, Genome Biol, vol.8, p.215, 2007. ,
breast cancer study group of the Institut Curie. Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast, Clin Cancer, vol.14, pp.1956-1965, 2008. ,
Loss, mutation and deregulation of L3MBTL4 in breast cancers, Mol Cancer, vol.9, p.213, 2010. ,
Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients, Clin Cancer Res, vol.16, pp.651-663, 2010. ,
Genome profiling of ERBB2-amplified breast cancers, BMC Cancer, vol.10, p.539, 2010. ,
Highresolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes, PLoS ONE, vol.6, p.16950, 2011. ,
ZNF703 gene amplification at 8p12 specifies luminal B breast cancer, EMBO Mol Med, vol.3, pp.153-166, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01431945
DNA methylation epigenotypes in breast cancer molecular subtypes, Breast Cancer Res, vol.12, p.77, 2010. ,
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns, Breast Cancer Res, vol.12, p.36, 2010. ,
Arraybased DNA methylation profiling for breast cancer subtype discrimination, PLoS One, vol.5, pp.12616-12625, 2010. ,
Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence, Cancer Res, vol.71, pp.6195-6207, 2011. ,
Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity, Cancer Res, vol.71, pp.2988-2999, 2010. ,
Identification of fusion genes in breast cancer by paired-end RNA-sequencing, 2011. ,
, Genome Biol, vol.12, p.6
Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines, BMC Med Genomics, vol.4, p.75, 2011. ,
Sequence analysis of mutations and translocations across breast cancer subtypes, Nature, vol.486, pp.405-409, 2012. ,
, Comprehensive molecular portraits of human breast tumours, Cancer Genome Atlas Network, vol.490, pp.61-70, 2012.
Whole-genome analysis informs breast cancer response to aromatase inhibition, Nature, vol.486, pp.353-360, 2012. ,
The clonal and mutational evolution spectrum of primary triple-negative breast cancers, Nature, vol.486, pp.395-399, 2012. ,
The landscape of cancer genes and mutational processes in breast cancer, Nature, vol.20486, pp.400-404, 2012. ,
Luminal-B breast cancer and novel therapeutic targets, Breast Cancer Res, vol.13, p.221, 2011. ,
CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer, Br J Cancer, vol.101, pp.1824-1832, 2009. ,
Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance, Breast Cancer Res Treat, vol.130, pp.409-420, 2011. ,
Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines, Int J Cancer, vol.131, pp.1998-2007, 2012. ,
TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRa gene expression, Cancer Cell, vol.21, pp.563-576, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00739947
A simple p53 functional assay for screening cell lines, blood, and tumors, Proc Natl Acad Sci U S A, vol.92, pp.3963-3967, 1995. ,
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen, PLoS Med, p.90, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00700961
REporting recommendations for tumor MARKer prognostic studies (REMARK), Breast Cancer Res Treat, vol.100, pp.229-235, 2006. ,
Circos: an information aesthetic for comparative genomics, Genome Res, vol.19, pp.1639-1645, 2009. ,
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets, Gut, vol.61, pp.673-684, 2012. ,
Combinatorial patterns of somatic gene mutations in cancer, Faseb J, vol.22, pp.2605-2622, 2008. ,
Objective assessment of cancer genes for drug discovery, Nat Rev Drug Discov, vol.12, pp.35-50, 2013. ,
Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3f, FOXM1, and a gene signature associated with mitosis, Breast Cancer Res, vol.13, p.70, 2011. ,
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer, Cancer Res, vol.68, pp.7165-7175, 2008. ,
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium, EMBO Mol Med, vol.3, pp.167-180, 2011. ,
RCP is a human breast cancer-promoting gene with Ras-activating function, J Clin Invest, vol.119, pp.2171-2183, 2009. ,
Intrinsic breast cancer subtypes defined by estrogen receptor signallingprognostic relevance of progesterone receptor loss, Mod Pathol, vol.26, pp.1161-1171, 2013. ,
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse, Ann Oncol, vol.24, pp.661-668, 2013. ,
Supervised risk predictor of breast cancer based on intrinsic subtypes, J Clin Oncol, vol.27, pp.1160-1167, 2009. ,
Breast cancer molecular profiling with single sample predictors: a retrospective analysis, Lancet Oncol, vol.11, pp.339-349, 2010. ,
RecQL4 Helicase Amplification Is Involved in Human Breast Tumorigenesis, PLoS One, vol.8, p.69600, 2013. ,
Mutations and deletions of ARID1A in breast tumors, Oncogene, vol.31, pp.4255-4256, 2012. ,
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer, Cancer Res, vol.70, pp.2085-2094, 2010. ,
Coamplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis, Oncogene, vol.28, pp.1892-1903, 2009. ,
High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1, Genes Chromosomes Cancer, vol.50, pp.775-787, 2011. ,
, Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, 2013.
FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma, PLoS One, vol.7, p.34329, 2012. ,
miRBase: microRNA sequences, targets and gene nomenclature, Nucleic Acids Res, vol.34, pp.140-144, 2006. ,
RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer, Cancer Res, vol.66, pp.6512-6520, 2006. ,
RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor a, Oncogene, vol.31, pp.527-534, 2012. ,
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation, Cell, vol.117, pp.421-426, 2004. ,
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis, Breast Cancer Research, vol.10, p.21, 2008. ,
FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer, Breast Cancer Research and Treatment, vol.129, pp.11-21, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00615379
Steroid hormone receptors in the management of human breast cancer, Ann Clin Res, vol.12, pp.202-207, 1980. ,
Luminal breast cancer: from biology to treatment, Nat Rev Clin Oncol, vol.10, pp.494-506, 2013. ,
FOXM1: From cancer initiation to progression and treatment, Biochim Biophys Acta, vol.1819, pp.28-37, 2012. ,
Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts, Mol Cancer Ther, vol.10, pp.2287-2297, 2011. ,